Quarterly Transactions Made in Spdr Ser Tr Spdr S&P Biotech E (XBI)
This table provides information about the institutional ownership of Spdr Ser Tr Spdr S&P Biotech E (XBI). The information is specifically focused on institutions that hold shares of SPDR SER TR SPDR S&P BIOTECH E.
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q4 2021 | 9,148,078 | 9,107,572 | 18,255,650 | 9,152,908 | 1,089,373 | 10,242,281 | 8,013,369 | |
| Q1 2022 | 25,077,000 | 5,641,224 | 30,718,224 | 20,204,419 | 1,281,376 | 21,485,795 | 9,232,429 | |
| Q2 2022 | 18,132,175 | 9,520,590 | 27,652,765 | 15,561,645 | 4,290,761 | 19,852,406 | 7,800,359 | |
| Q3 2022 | 8,676,511 | 5,165,464 | 13,841,975 | 16,101,758 | 28,899 | 16,130,657 | -2,288,682 | |
| Q4 2022 | 14,999,573 | 9,494,260 | 24,493,833 | 9,270,522 | 10,841 | 9,281,363 | 15,212,470 | |
| Q1 2023 | 21,882,923 | 2,069,865 | 23,952,788 | 17,377,570 | 72 | 17,377,642 | 6,575,146 | |
| Q2 2023 | 16,373,836 | 2,138,686 | 18,512,522 | 16,287,852 | 0 | 16,287,852 | 2,224,670 | |
| Q3 2023 | 12,938,411 | 3,339,637 | 16,278,048 | 4,961,292 | 29,567 | 4,990,859 | 11,287,189 | |
| Q4 2023 | 10,086,549 | 10,027,037 | 20,113,586 | 34,179,523 | 72 | 34,179,595 | -14,066,009 | |
| Q1 2024 | 30,591,293 | 3,792,719 | 34,384,012 | 14,615,521 | 0 | 14,615,521 | 19,768,491 | |
| Q2 2024 | 13,111,960 | 1,947,554 | 15,059,514 | 14,620,673 | 161,891 | 14,782,564 | 276,950 | |
| Q3 2024 | 13,922,158 | 4,677,405 | 18,599,563 | 8,691,459 | 1 | 8,691,460 | 9,908,103 | |
| Q4 2024 | 23,843,323 | 9,103,357 | 32,946,680 | 20,245,037 | 170,100 | 20,415,137 | 12,531,543 | |